The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development.
Source: hbr.org
Author: Ryan Copping and Michael Li
Advertisements
Categories: Articles